| Cell Source, Inc. |
Director |
Common Stock |
115K |
$86.2K |
$0.75 |
30 Jun 2021 |
Direct |
| Cell Source, Inc. |
Director |
Director Stock Option (Right to Buy) |
450K |
|
|
19 Aug 2020 |
Direct |
| Kintara Therapeutics, Inc. |
Chief Scientific Officer |
Options (Right to Buy) |
10.2K |
|
|
30 Aug 2023 |
Direct |
| Cell Source, Inc. |
Director |
Series A Convertible Preferred Stock |
6.67K |
|
|
13 Feb 2019 |
Direct |
| Kintara Therapeutics, Inc. |
Chief Scientific Officer |
Common Stock, par value $0.001 per share |
5.3K |
|
|
05 Jan 2023 |
Direct |
| Kintara Therapeutics, Inc. |
Chief Scientific Officer |
Common Stock, par value $0.001 per share |
1.08K |
|
|
05 Jan 2023 |
Indirect |